Pharmaceutical cost distribution in childhood chronic kidney disease

Pediatric Nephrology

Volumn 27, Issue 9, 2012, Pages 1531-1539

  Dionne, Janis M ^a   Lou, Kelvin ^a   Er, Lee ^b   Collin, Kathleen ^a   White, Colin T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b British Columbia Provincial Renal Agency   (Canada)

Author keywords

Anemia; Cost analysis; Drug costs; Medication adherence; Metabolic bone diseases; Nutritional requirements; Pediatrics

Indexed keywords

BICARBONATE; CARBOHYDRATE; MAGNESIUM; MULTIVITAMIN; PHOSPHATE; POTASSIUM; PROTEIN; SODIUM; VITAMIN D;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BONE METABOLISM; CANADA; CHILD; CHILD GROWTH; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COST BENEFIT ANALYSIS; DIET SUPPLEMENTATION; DRUG COST; HUMAN; HYPERTENSION; INFANT; MEDICAL RECORD REVIEW; NUTRITION; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TERTIARY HEALTH CARE; VITAMIN SUPPLEMENTATION;

ADOLESCENT; CANADA; CHILD; CHILD, PRESCHOOL; DRUG COSTS; FEMALE; HUMANS; INFANT; MALE; PHARMACEUTICAL PREPARATIONS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84864480507     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2165-1     Document Type: Article

References (30)

1. Vupputuri S (2008) Epidemiology and costs of chronic kidney disease in North Carolina. N C Med J 69:205-214
2. London R, Solis A, Goldberg G, Wade S, Chan W (2003) Examination of resource use and clinical interventions associated with chronic kidney disease in a managed care population. J Manag Care Pharm 9:248-255
3. Khan S, Amedia C Jr. (2008) Economic burden of chronic kidney disease. J Eval Clin Pract 14:422-434 (Pubitemid 351643256)
4. Smith D, Gullion C, Nichols G, Keith D, Brown J (2004) Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 15:1300-1306 (Pubitemid 38526011)
5. van Hout B, Simeon G, McDonnell J, Mann J (1997) Economic evaluation of benazepril in chronic renal insufficiency. Kidney Int Suppl 63:S159-S162 (Pubitemid 28020458)
6. Ruggenenti P, Schieppati A, Remuzzi G (2001) Progression, remission, regression of chronic renal diseases. Lancet 357:1601-1608 (Pubitemid 32488830)
7. Gregory D, Sarnak M, Konstam M, Pereira B, Salem D (2003) Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunction. Am J Cardiol 92:1300-1305 (Pubitemid 37431138)
8. White C, Jaffey J, Magner P (2006) Cost of applying the K/DOQI guidelines for bone metabolism and disease to a cohort of chronic hemodialysis patients. Kidney Int 71:312-317
9. St Peter W, Khan S, Ebben J, Pereira B, Collins A (2004) Chronic kidney disease: the distribution of health care dollars. Kidney Int 66:313-321 (Pubitemid 38870108)
10. Lefebvre P, Duh M, Buteau S, Bookhart B, Mody S (2006) Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease. J Am Soc Nephrol 17:3497-3502 (Pubitemid 44865292)
11. Matsui D (1997) Drug compliance in pediatrics: clinical and research issues. Pediatr Clin North Am 44:1-14 (Pubitemid 27102452)
12. Census of Canada. Available at: http://www12.statcan.ca/ censusrecensement/index-eng.cfm. Accessed 16 June 2011
13. Hogg R, Furth S, Lemley K, Portman R, Schwartz G, Coresh J, Balk E, Lau J, Levin A, Kausz A, Eknoyan G, Levey A (2003) National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416-1421 (Pubitemid 36682280)
14. Mattman A, Eintracht S, Mock T, Schick G, Seccombe D, Hurley R, White C (2006) Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging. J Am Soc Nephrol 17:487-496
15. BC PharmaCare (2010) BC PharmaCare newsletter edn 10-007. Available at: www.health.gov.bc.ca/pharmacare
16. Steiner J, Koepsell T, Fihn S, Inui T (1988) A general method of compliance assessment using centralized pharmacy records: description and validation. Med Care 26:814-823
17. Steiner J, Prochazka A (1997) The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 50:105-116 (Pubitemid 27089212)
18. London R, Solis A, Goldberg G, Wade S, Ryu S (2002) Health care resource utilization and the impact of anemiamanagement in patients with chronic kidney disease. Am J Kidney Dis 40:539-548 (Pubitemid 34971283)
19. North American Pediatric Renal Trials and Collaborative Studies Online (2008) NAPRTCS 2008 annual report: renal transplantation, dialysis, chronic renal insufficiency. Available at: https://web.emmes.com/study/ped/annlrept/ annlrept.html
20. Brand F, Smith R, Brand P (1977) Effect of economic barriers to medical care on patients' noncompliance. Public Health Rep 92:72-78 (Pubitemid 8128170)
21. Pons R, Torregrosa E, Hernandez-Jaras J, Garcia H, Rius A, Calvo C, Sanchez-Canel J, Pin M, Mauduell F (2006) El coste de tratamiento farmacologico en la enfermedad renal cronica. Nefrología 26:358-364 (Pubitemid 44898044)
22. Wong H, Mylrea K, Feber J, Drukker A, Filler G (2006) Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int 70:585-590 (Pubitemid 44141587)
23. Fadrowski J, Pierce C, Cole S, Moxey-Mims M, Warady B, Furth S (2008) Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 3:457-462
24. Levin A, Bakris G, Molitch M, Smulders M, Tian J, Williams L, Andress D (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in paitents with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31-38 (Pubitemid 44967731)
25. Chiu Y, Teitelbaum I, Misra M, de Leon E, Adzize T, Mehrotra R (2009) Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 4:1089-1096
26. Modi A, Lim C, Yu N, Geller D, Wagner M, Quittner A (2006) A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros 5:177-185 (Pubitemid 44063951)
27. Fotheringham M, Sawyer M (1995) Adherence to recommended medical regimens in childhood and adolescence. J Paediatr Child Health 31:72-78
28. Canadian Cystic Fibrosis Foundation. About cystic fibrosis. Available at: http://www.cysticfibrosis.ca/en/aboutCysticFibrosis/index.php. Accessed 13 Sept 2010
29. Bailie G, Eisele G, Liu L, Roys E, Kiser M, Finkelstein F, Wolfe R, Port F, Burrows-Hudson S, Saran R (2005) Patterns of medications use in the RRI-CKD study: focus on medications with cardiovascular effects. Nephrol Dial Transplant 20:1110-1115 (Pubitemid 40862099)
30. Tomasello S, Dhupar S, Sherman R (2004) Phosphate binders, K/DOQI guidelines, and compliance: the unfortunate reality. Dial Transplant 33:236-242